• CVS Health completes acquisition of Aetna for $69bn pharmaceutical-technology
    November 30, 2018
    CVS Health has completed its acquisition of all outstanding shares of healthcare benefits provider Aetna in a deal valued at $69bn......
  • WuXi NextCODE Invests $400M to Expand Precision Medicine Efforts in Ireland contractpharma
    November 30, 2018
    WuXi NextCODE, a life sciences informatics company, has unveiled its plan to create in Ireland a dataset for genome-driven drug discovery and create a model for delivering the benefits of precision medicine.
  • Genentech Acquires Jecure Therapeutics americanpharmaceuticalreview
    November 29, 2018
    Jecure Therapeutics announced a definitive agreement by which it will be acquired by Genentech, a member of the Roche Group. With this acquisition, Genentech will obtain full rights to Jecure’s entire preclinical portfolio of NLRP3 inhibitors......
  • Sun Pharmaceutical agrees to acquire Japan’s Pola Pharma pharmaceutical
    November 29, 2018
    India-based drugmaker Sun Pharmaceutical Industries has signed a definitive agreement to acquire Pola Pharma, a Japan-based pharma firm involved in the research, development, manufacture, and sale of branded and generic products......
  • Q BioMed Acquires Metastron from GE Healthcare americanpharmaceuticalreview
    November 29, 2018
    Q BioMed has entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron, from GE Healthcare....
  • Two Labs Acquires Pennside Partners Ltd. pharmafocusasia
    November 28, 2018
    Industry-leading pharmaceutical services company, Two Labs, today announced it has acquired Pennside Partners Ltd., an international provider of market insights....
  • Endocyte Enters Into Agreement to be Acquired by Novartis AG for $2.1 Billion pharmafocusasia
    November 28, 2018
    Endocyte, Inc., a biopharmaceutical company developing targeted therapeutics for cancer treatment, today announced that it has entered into an agreement .....
  • Cherry acquired by communications group Avenir pharmaphorum
    November 28, 2018
    UK healthcare creative agency Cherry has been acquired by Avenir Global in a move that strengthens its European presence.
  • Cambrex Buys Avista for $252M contractpharma
    November 27, 2018
    Cambrex has entered into a definitive agreement to acquire Avista Pharma Solutions for roughly $252 million. Avista is a portfolio company of Ampersand Capital Partners.
  • Telix to Acquire ANMI for €5.15M contractpharma
    November 27, 2018
    Telix Pharmaceuticals Limited has announced the acquisition of Advanced Nuclear Medicine Ingredients (ANMI) SA for €5.15m in cash and shares.
PharmaSources Customer Service